You are here

Japan biotech venture PeptiDream a US$3b business

Mr Kubota (right) and Prof Suga, whose lab developed an artificial ribozyme, which he named flexizyme for its "promiscuous" ability to help amino acids couple to form peptides.


WHEN he realised he wasn't going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.

Many years spent fiddling with the building blocks of the universe - combining molecules to form compounds - led...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to